RecruitingNot Applicable

Hyaluronic Acid-enriched Transfer Medium in Single Blastocyst Transfer

China858 participantsStarted 2024-09-13

Plain-language summary

The purpose of this study is to compare the live birth rates of high concentration of Hyaluronic Acid (0.5 mg/ml) transfer medium (EmbryoGlue®) to those containing low Hyaluronic Acid concentrations (0.125 mg/ml) (G2 medium) in women undergoing single fresh and frozen blastocyst transfer.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. All cycles with single blastocyst transfer will be considered eligible
✓. Both fresh and cryopreserved embryo transfer cycles utilizing autologous oocytes
✓. No age restriction will be applied
✓. Informed consent was signed

Exclusion criteria

✕. Uterine anatomic anomalies
✕. Women with untreated hydrosalpines
✕. Once couples have been enrolled in the trial, subsequent cycles will not be incorporated.

What they're measuring

Live birth rate

Timeframe: Live birth is defined as the birth of at least one live baby after 24 weeks of gestation.

Trial details

NCT IDNCT06492785

SponsorNorthwest Women's and Children's Hospital, Xi'an, Shaanxi

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-31

Contact for this trial

He Cai, Doctor

13581613908 caihe@bjmu.edu.cn

View on ClinicalTrials.gov More Infertility trials